• MicuRx Commits Funding for Development of MRX-8 americanpharmaceuticalreview
    August 18, 2020
    MicuRx Pharmaceuticals announced the global partnership Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has committed up to US$7.78 million of nondilutive financing for a Phase 1 clinical trial and related R&D activities ...
PharmaSources Customer Service